News and Information
Investor
Environmental Protection Acceptance Monitoring Report (Revised) for the Completion of the Project of Zhejiang Aoxiang Pharmaceutical Co., Ltd. with an Annual Production of 20 Tons of PLST, 10 Tons of COKT, and Other Active Pharmaceutical Ingredients and Key Drug Intermediates (Pilot)
Release Date:
2023-12-15
Related News
In recent years, Aoxiang Pharmaceutical has, while maintaining its core strengths in active pharmaceutical ingredients, steadfastly implemented a “transformation and upgrading” strategy, prioritizing the research and development of peptide drugs, oligonucleotides, and synthetic biology technologies.
2026-01-13
Email:
Company Address:
No.5, Donghai 4th Avenue, Zhejiang Chemical Materials Base Linhai Zone, Taizhou,Zhejiang,China
